source Post navigation New study concludes diabetes and weight-loss drugs—Ozempic and Wegovy—not associated with increased risk for … – The Daily | Case Western Reserve University Understanding the Role of GLP-1R Agonists in Improving Insulin Sensitivity and Reducing Diabetes Risk – Medriva
